#SYNTHEMA enables research on diseases like leukaemia and sickle cell without exposing patient data, using AI-generated synthetic datasets. Our models create realistic clinical, genetic, and imaging data, supporting safe and privacy-first research. 👉 synthema.eu #AIInMedicine

If you're interested in regulation and ethics in AI for healthcare, don’t miss this session on MDR, the EU AI Act and privacy-preserving federated learning as part of the joint #SYNTHEMA and @erneurobloodnet.bsky.social training programme. 👉 Register: synthema.eu/training/

Missed it? The BDVA Healthcare Task Force white paper on synthetic data features #SYNTHEMA, led by Netcompany, alongside AISym4MED and SECURED. It shows how synthetic data can expand access, improve AI and enable more inclusive research. Access the paper: synthema.eu/publications/

Join the first #SYNTHEMA webinar in our training series! 8 May 2026 | 12:30 CEST Explore the @erneurobloodnet.bsky.social infrastructure for synthetic data: governance, strategy & architecture. Open to patients & health professionals. 👉 synthema.eu/training/ Don’t miss it & share!

🚀​Are you ready to explore the cutting-edge world of Artificial Intelligence in hematology? ERN-EuroBloodNet and @synthemaeu.bsky.social are proud to launch a joint educational program on #AI, designed for both the public-at-large and expert audiences. eurobloodnet.eu/education-2/...

Registration is open for the SYNTHEMA & @erneurobloodnet.bsky.social in haematology webinar series. Join all 4 sessions in May 2026 or register for individual webinars. Synthetic data, federated learning, regulation and clinical use cases in AML and SCD. Register: synthema.eu/training/

Good data is not just collected, it is built with care. In #SYNTHEMA, clinical teams across Europe are creating high-quality, privacy-compliant datasets to power synthetic data and AI research in rare blood disorders. 👉Read more: synthema.eu/2025/09/23/d...

Netcompany has published the SYNTHEMA SMPC federated learning app on the Flower Hub. It enables secure aggregation of model updates while keeping data private. 👉 Explore the app: flower.ai/apps/synthem...

Research on rare hematological diseases depends on people committed to complex challenges. Within SYNTHEMA, women contribute across clinical research, data science, technology and project work. Today, on March 8, we spotlight their contributions and give them the recognition they deserve.

At #SYNTHEMA we use AI to fill data gaps & improve care for rare blood disorders. Focusing on Sickle Cell Disease & Acute Myeloid Leukaemia, we integrate clinical, genetic & imaging data for improved patient outcomes. 👉 synthema.eu #RareDiseases #Haematology

28/02 is Rare Disease Day. It is about connection across countries, disciplines and communities. Progress in rare diseases depends on visibility, collaboration and responsible data use. At SYNTHEMA, we support cross-border research in rare hematological diseases synthema.eu

Interested in synthetic data and AI-powered breakthroughs in hematology? Visit SYNTHEMA’s publications section to explore the latest advancements by our team in data privacy, federated learning, AI for rare blood diseases, and more. 👉 Start reading: synthema.eu/publications/ #SYNTHEMA

SYNTHEMA uses smart AI to help scientists study diseases like leukaemia and sickle cell without using real patient data. These models learn from medical records and create new, realistic examples, such as lab results or scans, while keeping privacy fully protected. 👉 synthema.eu

Scientific progress depends on who gets to take part. In #SYNTHEMA, women contribute as researchers, clinicians and data specialists across all stages of the work. This day draws attention to how scientific careers are accessed: synthema.eu/2025/02/11/b...

A worth conference to keep an eye on, with a focus on AI applications and concrete clinical cases in rare diseases, alongside patient perspectives.

At SYNTHEMA, we support cancer research in rare haematological diseases such as Acute Myeloid Leukaemia by developing privacy preserving synthetic clinical and genomic data, helping survival and treatment response research where patient numbers are limited. 👉 Learn more: synthema.eu/use-cases/

It’s not enough for synthetic data to look real, it must be clinically useful. #SYNTHEMA tests if it can predict outcomes, reveal genetic risks & support real diagnoses. Synthetic data means real impact. 👉 synthema.eu #SyntheticData #AIHealthcare

Rare disease research can’t be equitable if data stay scarce or siloed. At SYNTHEMA, we tackle these barriers with GDPR-compliant AI and synthetic data, expanding the evidence base for rare hematological diseases so innovation can benefit patients everywhere. 👉 synthema.eu

Subscribe to the SYNTHEMA newsletter to receive key project updates and announcements about important activities, all in one place. Clear, relevant, and focused on what matters. Choose the format: 📩 by email: f981d420.sibforms.com/serve/MUIEAH... 💼 on LinkedIn: www.linkedin.com/newsletters/...

The Synthema and GenoMed4All consortia have developed an AI framework to refine myeloid neoplasm diagnosis and prognosis. By extracting features from bone marrow images, the team achieved diagnostic accuracy exceeding 90%.

#SYNTHEMA is part of the #HealthData4EU cluster, an alliance of EU-funded projects addressing fragmentation in health data across Europe through synthetic data generation, federated learning, and privacy-preserving technologies. Laarn more: synthema.eu/healthdata4eu/

How can AI improve precision medicine in hematology? The GEMINI Digital Twin platform, developed by the #SYNTHEMA & #GenoMed4Al consortia, integrates multimodal real-world data from 22,080 MDS patients to personalize clinical decision-making. #MDS #Hematology #DigitalTwin

We start this year sharing that registrations are now open for ECRD 2026, taking place on 3–4 June 2026 in Prague and online. The conference addresses European policy priorities on rare diseases, including rare hematological diseases. Early-bird registration is available until 26 February 2026.

A short holiday break is approaching. Wishing partners, colleagues and everyone following #SYNTHEMA a peaceful holiday period, whatever it may look like for you. Thank you for being part of a community committed to responsible research in rare hematological diseases. synthema.eu

PW FedAvg, a new method by UPM researchers, improves treatment effect estimation in federated healthcare settings with imbalanced treatment distributions. It reduces causal inference errors where traditional FL methods fall short. 👉 synthema.eu/publications/ #SYNTHEMA #FederatedLearning

#SYNTHEMA joined the i~HD Annual Conference, with Elisabetta Mezzalira (University of Padova) representing the project. The event featured the presentation of the #HealthData4EU white paper “Building Trust in Synthetic Health Data”. #SyntheticHealthData

How similar is synthetic tabular data to the real thing? This new approach uses KL and JS divergences to evaluate full joint distributions — not just feature by feature. A more reliable way to validate synthetic datasets in practice. 👉 synthema.eu/publications/ #SyntheticData #DataValidation #AI

Over 450 haematological diseases affect blood cells, the lymphatic system & coagulation, posing major challenges to public #HealthSystems. #SYNTHEMA is developing a secure platform for synthetic #ClinicalData to enable GDPR-compliant research in rare #HaematologicalDiseases. 👉 synthema.eu

Can synthetic tabular data be more accurate? This new model by researchers at Universidad Politécnica de Madrid combines a Variational Autoencoder with a Gaussian Mixture Model. Results outperform #CTGAN and #TVAE, especially on medical datasets. 👉 synthema.eu/publications/ #SYNTHEMA

The paper “Distributing trust: A P2P SMPC protocol for secure federated learning” by Petros Demetrakopoulos, Themistoklis Anagnostopoulos and Sofia Tsekeridou (Netcompany RID, #SYNTHEMA partner) will be presented at #FLLM2025 on 27 Nov at 15:30. synthema.eu

#HealthData4EU Cluster is at #EBDVF25 this week. SYNTHEMA isn’t on site, but we’re glad to support tomorrow’s session in Copenhagen. If you're there on 14 Nov, join “Ecosystems of Innovation in Healthcare” from 09:00–10:30, Room 2.B — a chance to hear how our partners advance ethical health data use

How well does synthetic data generation work when spread across multiple hospitals? This study on #AML shows that federated learning protects privacy, though fidelity takes a hit. A key step in real-world AI for rare diseases. 👉 synthema.eu/publications @vicomtech.bsky.social #SYNTHEMA

Two productive days in San Sebastian for the #SYNTHEMA consortium have come to an end. Lively discussions, clear goals for the final year: a recap publication on synthetic data in haematology, joint training with @erneurobloodnet.bsky.social, new papers, and the SYNTHEMA platform launch synthema.eu

The SYNTHEMA consortium is meeting in San Sebastian, Spain, to mark the project’s third anniversary and kick off discussions for the final year ahead. Together, we’re committed to delivering results in secure, AI-powered health data for rare hematological diseases. 👉 synthema.eu

What can generative models reveal about the real data they learn from? This study by @upm.es researchers explores membership inference attacks in generative models, introducing new theory and showing how differential privacy fits in. A critical read for privacy-aware AI: synthema.eu/publications/

Pushing the boundaries of AI-based research in rare haematological diseases. #SYNTHEMA develops privacy-preserving AI and synthetic data to create virtual patients that improve diagnosis and treatment in rare diseases. 👉 synthema.eu #AIinHealthcare #HorizonEurope

The #HealthData4EU Cluster, which SYNTHEMA forms part of, will host the session “Ecosystems of Innovation in Healthcare: Ensuring Trust, Quality & Ethics in Data Use” at #EBDVF2025 in Copenhagen on 12–14 Nov Event: european-big-data-value-forum.eu/2025-edition... Cluster: synthema.eu/healthdata4eu/

Most synthetic data models assume data abundance. This study shows how transfer learning and meta-learning improve synthetic data generation for cancer research in low-data scenarios, where real clinical constraints apply. 👉 synthema.eu/publications/ #SYNTHEMA #SyntheticData #AI

Our partner i~HD is hosting a special 10th anniversary edition of its Annual Conference: “A Decade of Joining the Dots – Towards Bridging Data Spaces” 📍 3–4 Dec 2025 | Ghent, Belgium Topics: EHDS, AI in healthcare, data quality, privacy & governance. 👉 www.i-hd.eu/ac2025

Most synthetic data models assume data abundance. This study shows how transfer learning and meta-learning improve synthetic data generation for cancer research in low-data scenarios, where real clinical constraints apply. 👉 synthema.eu/publications/ #SYNTHEMA #CancerResearch

In #SYNTHEMA, data collection is central to building GDPR-compliant, AI-ready datasets for Sickle Cell Disease and Acute Myeloid Leukaemia. Harmonised across countries, the data supports synthetic generation, federated learning, and future rare disease research. 👉 synthema.eu/2025/09/23/d...

Data scarcity and fragmentation limit synthetic data in healthcare. This study introduces Synthetic Data Sharing, a federated learning method that improves representativeness and reduces disparities between data-rich and data-poor institutions. 👉 synthema.eu/publications/ #SYNTHEMA

Good data is not just collected, it is built with care. In #SYNTHEMA, clinical teams across Europe are creating high-quality, privacy-compliant datasets to power synthetic data and AI research in rare blood disorders. 👉Read more: synthema.eu/2025/09/23/d...

Cyber-physical systems need smarter tools for risk assessment. This study introduces an automated, simulation-based method aligned with ISO 27005. Validated through a real attack case and implemented in Spyderisk. Read more 👉 synthema.eu/publications/

📰 The #BDVA Healthcare Task Force has published its white paper on Synthetic Data in Healthcare. Proud to contribute alongside AISym4Med & SECURED, our sister projects in the #HEALTHDATA4EU cluster. Read more 👉 bdva.eu/news/synthet... #SyntheticData #SYNTHEMA

#SYNTHEMA is featured in The Innovation Platform (Issue 23), with an article on how synthetic data and federated AI are transforming research in rare blood disorders while keeping patient privacy at the core: www.innovationnewsnetwork.com/publication/... #SyntheticData #RareDiseases

The #SYNTHEMA platform enables synthetic health data without moving sensitive patient info. ✔️ Data stays local ✔️ Federated learning across centres ✔️ FAIR-based quality & compliance Tested in #SCD & #AML use cases. More info: synthema.eu

#SYNTHEMA is building the foundations for a future where synthetic, privacy-preserving data supports progress in rare diseases. Beyond its two use cases, its flexible design can benefit other rare and underrepresented conditions. More 👉 synthema.eu

Estimating treatment effects in healthcare is complex when data is decentralized and privacy is critical. This study applies federated learning to generative causal models for privacy-preserving ITE estimation across fragmented datasets. 👉 synthema.eu/publications/ #SYNTHEMA

Local data stays safe. Global research moves forward. With SYNTHEMA’s federated learning, hospitals never share patient data, but together they unlock new possibilities for rare disease research. 👉 synthema.eu